Iribarren ME, et al. Experience with Mepolizumab in a cohort of patients with eosinophilic severe persistent asthma. P2520. ERS 2019, 28 sep.-2 okt. 2019, Madrid, Spanje.
Combinatie JAK-remmer en anti-PD-1 bij gemetastaseerd NSCLC
sep 2024 | Immuuntherapie, Longoncologie